• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Jobs
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • OMRF in the Media
    • OMRF News
    • OMRF Publications
    • OMRF Videos
    • Dr. Prescott’s Columns
  • Patients
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Syndrome
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for commercialization

commercialization

OMRF hosts national biotechnology forum

April 4, 2017

Visiting attendees represented some of the top names in in the industry.

Filed Under: News, Technology Ventures News Tagged With: 2017, 5am, abbvie, AstraZeneca, biotechnology, BioVenture, business, collaboration, commercialization, discovery, drug companies, forge, forum, industry, investment, joseph miletich, keynote, Lijun, Lijun Xia, lilly ventures, Mayo Clinic, merck, OKC, Oklahoma City, Oklahoma Medical Research Foundation, OMRF, partner, Pfizer, research, science, scientist-news, stephen prescott, technology, technology ventures, Xia

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Charity navigator
United Way Give Smart OKC
Facebook Twitter YouTube Instagram Mail Linkedin
Administrator Log In